Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07237295 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CommunityRx-Kidney Health

Study acronym: CRx-K
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Final enrollment: 23 participants — 4% of the 634 planned Enrollment closed, study ongoing · Primary completion date changed from estimate of Jun 2028 to Sep 8, 2026 · Completion moved earlier from Jun 2028 to Oct 2026 · 1 more Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Primary completion date changed from estimate of Jun 2028 to Sep 8, 2026
    • Completion moved earlier from Jun 2028 to Oct 2026
    • Site details revised
  2. Eligibility criteria expanded, about 6 words Secondary endpoints: details revised at 8 of 8 entries Show 1 more changeShow less
    • Secondary endpoints: details revised at 8 of 8 entries
  3. Primary and study completion pushed from Dec 2027 to Jun 2028 Start date changed from estimate of Mar 2026 to Apr 13, 2026v4 Show 1 more changeShow less
    • Start date changed from estimate of Mar 2026 to Apr 13, 2026
  4. Trial status: Not Yet Recruiting to Recruiting Site details revisedv3 Show 1 more changeShow less
    • Site details revised
  5. Primary endpoints: 4 to 1 Start date: Jan 2026 to Mar 2026 · Interventions: CommunityRx-Chronic Kidney Disease (Behavioral) to CommunityRx-Kidney Health (Behavioral) · Secondary endpoints revised (8) · 3 morev2 Show 6 more changesShow less
    • Start date: Jan 2026 to Mar 2026
    • Interventions: CommunityRx-Chronic Kidney Disease (Behavioral) to CommunityRx-Kidney Health (Behavioral)
    • Secondary endpoints revised (8)
    • Study description shortened, about 14 words
    • Collaborators revised (8)
    • Study title shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care resources to improve CKD management in rural eastern North Carolina. Through a partnership among local primary care centers, community organizations, and researchers, CRx-K will strengthen rural care networks, improve CKD management, and enhance the well-being of rural communities.
Trial Details
NCT Number NCT07237295
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Goshen Medical Center, James McFarlin Community Development, Inc., Johns Hopkins University, Project GRACE, Project Momentum, Inc., UniteUs, University of Chicago
Conditions Chronic Kidney Disease (Stages 1-4)
Enrollment 23 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov